Stopping ‘turning away biz’ helps ERT grow sales in Q4
29-Feb-2012 By Nick Taylor
ERT ended 2011 on a high as its decision to stop ‘walking away from business’ helped it post double-digit sales growth.
EXCLUSIVE
28-Feb-2012 By Natalie Morrison
Reduced-pain injection systems are the key to gaining regulatory approval for new products, according to BD.
Rousselot announces gelatine price increases
28-Feb-2012
Ingredients manufacturer Rousselot has announced a price increase on its gelatine portfolio to balance out spiralling raw material costs.
28-Feb-2012 By Natalie Morrison
Quintiles is driving its clinical development services in the Russian Federation through a new alliance with Russian Venture Company (RVC).
Charles River & Millipore ally on viral clearance study technology
28-Feb-2012
Charles River has partnered with EMD Millipore to improve the consistency of the viral clearance studies it offers clients.
28-Feb-2012 By Nick Taylor
Marketing applications for heparin should cover traceability from slaughterhouses and other details of sourcing porcine mucosa, the EMA said.
28-Feb-2012 By Nick Taylor
A Chinese company that offers drug development services using a network of 99 third-party vendors has filed an $80m IPO.
Almost 30% of biopharma CEOs insourced work in ’11; survey
28-Feb-2012 By Nick Taylor
Almost 30 per cent of biopharma companies have insourced previously outsourced work in the past year, a PwC survey of CEOs found.
News from Biomatters, Seattle Genetics, and Permeon – People on the move
27-Feb-2012 By Natalie Morrison
in-PharmaTechnologist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Biomatters, Seattle Genetics, and Permeon.
27-Feb-2012 By Natalie Morrison
TIBCO and ChemAxon have combined forces over their chemical analysis software in a bid to “speed up and refine” the compound selection process.
27-Feb-2012
API sales at Latvia-based Grindeks jumped last year as it benefited from expanding its portfolio by 50 per cent.
Glenmark recalling birth control pills after packaging error
27-Feb-2012
Glenmark is recalling incorrectly packaged birth control pills from the US, less than one month after Pfizer took similar actions.
EXCLUSIVE
27-Feb-2012 By Natalie Morrison
Pharma companies must become more involved in building patient communities through social media if they want to see a successful trial recruitment process according to Patient Nucleus founder Jamie Blackburn.
27-Feb-2012 By Nick Taylor
The US FDA has published final guidance on the CMC data needed to support early phase trials of live biotherapeutics.
27-Feb-2012 By Nick Taylor
Sole suppliers that outsource manufacture must alert the FDA of interruptions at their CMOs, the Agency wrote in draft drug shortages guidance.
Brecon opens new facility citing 2011 partnership as driver
23-Feb-2012 By Gareth Macdonald
Brecon Pharmaceuticals has opened a new storage facility for clinical trial supplies citing higher demand following its partnership with Anderson.
23-Feb-2012
Inclinix has teamed up with JSW Life Sciences in a bid to ramp up its European patient recruitment capabilities.
FDA issues import alerts against 22 Chinese heparin suppliers
23-Feb-2012
The US FDA has issued import alerts against 22 Chinese heparin suppliers it claims ship adulterated product.
23-Feb-2012 By Nick Taylor
The US FDA has sent FSC Laboratories a warning letter for failing to set up a quality agreement with its contract manufacturer.
23-Feb-2012 By Natalie Morrison
Premier Research has doubled its clinical trials testing capacity with the launch of two research facilities in Phoenix and Salt Lake City, US.
23-Feb-2012 By Nick Taylor
S&P is predicting up to high single-digit near-term growth at Quintiles but rising costs and early phase capacity issues will pressure profits.
23-Feb-2012 By Nick Taylor
The US FDA has published draft guidance on drug shortages to clarify when and how manufacturers should report possible supply disruptions.
22-Feb-2012 By Natalie Morrison
Frontage Laboratories says it is focussing on improving regulatory and GMP compliance in China after signing a $10m (€7.5m) collaboration with drugs maker Fanghui Pharma.
EXCLUSIVE
22-Feb-2012 By Natalie Morrison
Bespak is on the hunt for more development contracts for its new nasal delivery platform.
22-Feb-2012 By Nick Taylor
Draft EU GDP guidelines would “significantly increase” supply-chain costs and be “virtually impossible” to carry out, big pharma and logistics companies said.
update
22-Feb-2012 By Gareth Macdonald
BASF has increased its European prices for ethanolamines (EOA) for the third time in as many months.
22-Feb-2012
Outsourcing-Pharma presents a round of new contract manufacturing deals, including business wins for Boehringer, Jubilant and Scynexis.
22-Feb-2012 By Nick Taylor
The US FDA is allowing Sun Pharma to import a version of Doxil to ease the drug shortage created by manufacturing failings at Ben Venue.
22-Feb-2012 By Gareth Macdonald
Warnex has pulled out of a C$1.1m (€833,000) deal to sell its analytical services business, alleging that the buyer failed to fulfil its obligations.
22-Feb-2012 By Gareth Macdonald
Freeman Technology says growing Pharma demand for analytical data prompted the formation of US subsidiary and it behind its plans for a new laboratory.
21-Feb-2012 By Natalie Morrison
Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials.
21-Feb-2012 By Nick Taylor
ACRO has told HHS the Physician Payments Sunshine Act is “highly problematic” for drug research and CROs in the US.
Ex-AstraZeneca staff open CRO near to closed UK R&D site
21-Feb-2012
Former AstraZeneca employees have created a niche drug discovery CRO near to the UK site the big pharma firm closed last year.
Pfizer and Mylan settle drug delivery patent case with Sanofi
21-Feb-2012
Pfizer and Mylan have settled patent litigation with Sanofi over a pre-filled drug delivery device used to treat allergic reactions.
21-Feb-2012 By Nick Taylor
Regulators should consider the impact of job cuts at manufacturing sites when drafting a risk-based GMP inspection plan, PIC/S said.
21-Feb-2012 By Natalie Morrison
Abbott Laboratories will pump €85m ($113m) into the expansion of its API production plant in Sligo, Ireland, in preparation of the launch of its pipeline products.
News from Patheon, CTI and PRECOS – People on the move
21-Feb-2012 By Natalie Morrison
Outsourcing Pharma presents its weekly round-up of the latest new faces and appointments in the pharmaceutical industry, including news from Patheon, CTI and PRECOS.
21-Feb-2012 By Gareth Macdonald
GE Healthcare has launched a new suite of bioprocess training courses in collaboration with a leading Singapore academic institution.
21-Feb-2012 By Nick Taylor
Researchers have said the outlook of drug discovery in India is “poor” after analysing intellectual property generated by CROs.
20-Feb-2012
Catalent has acquired Aptuit’s trial supplies business, six months after the multimillion dollar agreement was announced.
Venn Life Sciences & Encorium to merge, add working capital
20-Feb-2012
CROs Venn Life Sciences and Encorium are to merge and have secured working capital to expand the business.
20-Feb-2012 By Gareth Macdonald
Safety concerns prompt yet another recall at troubled US CMO Ben Venue with Bedford Labs pulling its leukaemia treatment cytarabine.
20-Feb-2012 By Nick Taylor
The MHRA has suspended the license for a Teva generic over suggestions its dissolution rate could affect interchangeability.
20-Feb-2012 By Nick Taylor
The value of RFPs sent to Icon in 2011 jumped 50 per cent as companies that have yet to ink strategic deals began bundling services.
16-Feb-2012 By Nick Taylor
Fourth quarter earnings at Icon missed analyst estimates and its guidance as an uptick in sales failed to offset rising costs.
16-Feb-2012 By Nick Taylor
The US FDA has sent West-Ward Pharmaceuticals a warning letter and asked for forewarning of any actions that may worsen drug shortages.
Genzyme recalling Fludara over CMO Ben Venue sterility fears
16-Feb-2012
Sterility fears have prompted Genzyme to recall 9,380 vials of Fludara manufactured by Ben Venue Laboratories.
16-Feb-2012 By Nick Taylor
Hospira hopes to ramp up output at its Rocky Mount facility in the second half of 2012 but warned it is “very difficult” to predict the remediation timeline.
16-Feb-2012 By Natalie Morrison
Quintiles has added to its commercial services capabilities in the Middle East and North Africa (MENA) region through an agreement with UAE-based Dayarn Pharma.
15-Feb-2012 By Natalie Morrison
Lonza has denied reports it has signed a deal with the South African government to build a $210m (€159m) API plant, saying it is merely “in discussions” over plans.
